← Eichor
Condition: Respiratory Syndrome Acute Severe Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Respiratory Syndrome Acute Severe

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Phase 1 · 2 location(s) · Shionogi · NCT07093580
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
Phase 3 · 32 location(s) · Direct Biologics, LLC · NCT05354141
Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05233605
Personalized Ventilation Based on Ventilation-perfusion Mismatch and Lung Recruitability
Phase N/A · 1 location(s) · Zhongda Hospital · NCT06430554
A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Ge
Phase N/A · 1 location(s) · Pfizer · NCT05890612
Effect of Different Depths of Neuromuscular Blockade on Respiratory Mechanics in Patients With Moderate-severe Acute Res
NA · 1 location(s) · Southeast University, China · NCT06514209
Imaging Immune Activation in COVID-19
Phase 2 · 1 location(s) · CellSight Technologies, Inc. · NCT04815096
KIDney Injury in Times of COVID-19 (KIDCOV)
Phase N/A · 3 location(s) · University of California, San Francisco · NCT04705766
Influence of Nutritional Indices on the Prognosis of Patients With SARS-CoV-2 Infection
Phase N/A · 1 location(s) · Juan Kang · NCT05835102
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Phase N/A · 1 location(s) · Brain Inflammation Collaborative · NCT04806620
Effects on Biotrauma of NMBAs and PP Association During ARDS
NA · 1 location(s) · Assistance Publique Hopitaux De Marseille · NCT06212492
Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma
Phase 3 · 1 location(s) · University Hospital, Strasbourg, France · NCT03368092
Infants with Severe Acute Respiratory Distress Syndrome: the Prone Trial
NA · 1 location(s) · Medical University of Vienna · NCT05002478
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Ye
Phase 3 · 73 location(s) · Pfizer · NCT05261139
Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and C
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04582903
The Impact of PEEP-guided Electrical Impedance Tomography on Oxygenation and Pulmonary Mechanics in Moderate-to-severe A
NA · 1 location(s) · Vietnam Military Medical University · NCT06733168
Presynaptic Imaging in Major Depressive Episodes After COVID-19
Phase N/A · 1 location(s) · Centre for Addiction and Mental Health · NCT06086366
Metabolic Reprogramming in Renal Tubular Cells in Acute Kidney Injury Following Severe Trauma
Phase N/A · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06167512
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
Phase 2 · 70 location(s) · BioAegis Therapeutics Inc. · NCT05947955
Ultra-protective Ventilation Monitored by Electrical Impedance Tomography in Patients With Severe Acute Respiratory Dist
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05717218
Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments
NA · 1 location(s) · Sunnybrook Health Sciences Centre · NCT06082518
Effect of Transpulmonary MP on Prognosis of Patients With Severe ARDS Treated With VV-ECMO
Phase N/A · 1 location(s) · Beijing Chao Yang Hospital · NCT06062212
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT05735717
Practices of Prone Positioning Ventilation in Patients With Moderate-to-Severe ARDS in Intensive Care Units: A Registry-
Phase N/A · 1 location(s) · Southeast University, China · NCT07284888
Full-Course ECMO Strategy for Moderate-to-Severe ARDS
NA · 39 location(s) · Southeast University, China · NCT07726953
Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT04579471
Convalescent Plasma as a Possible Treatment for COVID-19
Phase 2 · 1 location(s) · University of Illinois at Chicago · NCT04442191
Enteral Nutrition Delivery in Prone Position Ventilated Patients With Moderate to Severe ARDS
NA · 1 location(s) · Southeast University, China · NCT07362537
Positron Emission Tomography (PET) Imaging of Neuroinflammation in Patients With Neurological Dysfunction After Severe A
EARLY_Phase 1 · 1 location(s) · University of Alabama at Birmingham · NCT05656105
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
Phase N/A · 1 location(s) · Columbia University · NCT04448145
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.